Shigeki Kuriyama - Concepedia

Author

Shigeki Kuriyama

Also Known As

K Arashiba, Kuriyama, Sergio Noboru, S KURIYAMA, S Kuriyama, S. KURIYAMA, S. Kuriyama, S. Kuriyama, A. Mitoro, M. Yamazaki, S.N Kuriyama, S.N. Kuriyama, SHIGEKI KURIYAMA

289

Publications

9.3K

Citations

H-Index

200

Concepts

All Affiliations

Kagawa University Nara Medical University National Institute for Physiological Sciences Okazaki National Research Institutes Second Military Medical University

About

Shigeki Kuriyama is an author at Kagawa University specializing in medicine, pathology, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	38	97	4.5K
2	Health Sciences	13	13	1.1K
3	Engineering	5	5	200
4	Natural Sciences	5	5	183
5	Social Sciences	3	3	110

Shigeki Kuriyama

150

Publications

6.9K

Citations

H-Index

Page 1

	Year	Citations
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, Hepatology Liver FibrosisLiver Fibrosis DevelopmentPathologyAngiotensin-ii Type 1Pe Treatment	2001	382
Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene Tetsushi Kagawa, Kazuhiro Ikenaka, Yoshiro Inoue, Neuron Neurodegenerative DiseasesDevelopmental BiologyEpendymaMedicineDegenerative Disease	1994	267
Tissue Inhibitor of Metalloproteinases–1 Promotes Liver Fibrosis Development in A Transgenic Mouse Model Hitoshi Yoshiji, Shigeki Kuriyama, Yoji Miyamoto, Hepatology	2000	251
Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, Hepatology	2002	216
Cyclins and Cyclin–Dependent Kinases: Comparative Study of Hepatocellular Carcinoma Versus Cirrhosis Tsutomu Masaki, Yasushi Shiratori, William Rengifo, Hepatology	2003	208
Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis. Hitoshi Yoshiji, Shigeki Kuriyama, D. Kirk Ways, PubMed Cancer ResearchRadiation OncologyDevelopmental BiologyAngiogenesisSignal Transduction	1999	183
The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells Junichi Yoshii, Hitoshi Yoshiji, Shigeki Kuriyama, International Journal of Cancer Chemoprevention StrategyPathologyTumor BiologyHcc DevelopmentOncology	2001	169
Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats Hitoshi Yoshiji, Ryuichi Noguchi, Shigeki Kuriyama, American Journal of Physiology-Gastrointestinal and Liver Physiology Liver FibrosisPathologyCholangiopathiesRat ModelCirrhosis	2004	146
Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii, Hepatology	2002	146
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study Shinji Iwasaki, Hiromasa Ohira, Shuhei Nishiguchi, Hepatology Research HepatologyBiliary TractLiver PhysiologyPharmacologyGastroenterology	2008	139

Page 1